Chirivi, Renato G. S. http://orcid.org/0000-0003-4546-1559
van Rosmalen, Jos W. G.
van der Linden, Maarten http://orcid.org/0000-0001-8597-4151
Euler, Maximilien
Schmets, Gonny
Bogatkevich, Galina
Kambas, Konstantinos
Hahn, Jonas
Braster, Quinte
Soehnlein, Oliver
Hoffmann, Markus H. http://orcid.org/0000-0001-9698-9922
Es, Helmuth H. G. van
Raats, Jos M. H.
Article History
Received: 12 June 2019
Accepted: 10 February 2020
First Online: 20 March 2020
Competing interests
: R.G.S.C. and J.M.H.R. hold patents for different tACPA molecules. R.G.S.C., H.E., and J.M.H.R. are shareholders in Citryll B.V., which is developing tACPA for the treatment of human disease. The other authors declare no competing interests.